{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:07:28Z","timestamp":1770286048504,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s12328-023-01809-7","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T16:02:12Z","timestamp":1682697732000},"page":"572-579","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Histological improvement in chronic hepatitis C-autoimmune hepatitis overlap syndrome by glecaprevir and pibrentasvir"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4239-3063","authenticated-orcid":false,"given":"Kotaro","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Namura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Tsunashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinpei","family":"Doi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,28]]},"reference":[{"key":"1809_CR1","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/hep.1840120409","volume":"12","author":"K Kiyosawa","year":"1990","unstructured":"Kiyosawa K, Sodeyama T, Tanaka E, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology. 1990;12:671\u20135.","journal-title":"Hepatology"},{"key":"1809_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S1665-2681(19)30914-7","volume":"13","author":"EI Rigopoulou","year":"2013","unstructured":"Rigopoulou EI, Zachou K, Gatselis N, et al. Autoimmune hepatitis in patients with chronic HBV and HCV infections: patterns of clinical characteristics, disease progression and outcome. Ann Hepatol. 2013;13:127\u201335.","journal-title":"Ann Hepatol"},{"key":"1809_CR3","doi-asserted-by":"publisher","first-page":"588","DOI":"10.7326\/0003-4819-125-7-199610010-00009","volume":"125","author":"AJ Czaja","year":"1996","unstructured":"Czaja AJ. The variant forms of autoimmune hepatitis. Ann Intern Med. 1996;125:588\u201398.","journal-title":"Ann Intern Med"},{"key":"1809_CR4","doi-asserted-by":"publisher","first-page":"4394","DOI":"10.3748\/wjg.v13.i32.4394","volume":"13","author":"T Kogure","year":"2007","unstructured":"Kogure T, Ueno Y, Fukushima K, et al. Fulminant hepatic failure in a case of autoimmune hepatitis in hepatitis C during peg-interferonalpha 2b plus ribavirin treatment. World J Gastroenterol. 2007;13:4394\u20137.","journal-title":"World J Gastroenterol"},{"key":"1809_CR5","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00535-002-1090-7","volume":"38","author":"H Sezaki","year":"2003","unstructured":"Sezaki H, Arase Y, Tsubota A, et al. Type C-chronic hepatitis patients who had autoimmune phenomenon and developed jaundice during interferon therapy. J Gastroenterol. 2003;38:493\u2013500.","journal-title":"J Gastroenterol"},{"key":"1809_CR6","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S0168-8278(96)80009-2","volume":"24","author":"JL Calleja","year":"1996","unstructured":"Calleja JL, Albillos A, Cacho G, Iborra J, Abreu L, Escart\u00edn P. Interferon and prednisone therapy in chronic hepatitis C with nonorgan-specific antibodies. J Hepatol. 1996;24:308\u201312.","journal-title":"J Hepatol"},{"key":"1809_CR7","doi-asserted-by":"publisher","first-page":"632","DOI":"10.4254\/wjh.v8.i14.632","volume":"8","author":"F Sahebjam","year":"2016","unstructured":"Sahebjam F, Hajdu CH, Nortey E, et al. Direct acting antiviral therapy is curative for chronic hepatitis C\/autoimmune hepatitis overlap syndrome. World J Hepatol. 2016;8:632\u20136.","journal-title":"World J Hepatol"},{"key":"1809_CR8","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1159\/000475752","volume":"11","author":"A Sugiura","year":"2017","unstructured":"Sugiura A, Wada S, Mori H, et al. Successful treatment for chronic hepatitis C-autoimmune hepatitis overlap syndrome due to daclatasvir and asunaprevir. Case Rep Gastroenterol. 2017;11:305\u201311.","journal-title":"Case Rep Gastroenterol"},{"key":"1809_CR9","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/ajcp\/aqz095","volume":"152","author":"J Putra","year":"2019","unstructured":"Putra J, Schiano TD, Fiel MI. Resolution of HCV-autoimmune hepatitis overlap syndrome with antiviral treatment A paired liver biopsy study. Am J Clin Pathol. 2019;152:735\u201341.","journal-title":"Am J Clin Pathol"},{"key":"1809_CR10","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.hepres.2005.05.007","volume":"32","author":"H Takikawa","year":"2005","unstructured":"Takikawa H, Onji M. A proposal of the diagnostic scale of drug-induced liver injury. Hepatol Res. 2005;32:250\u20131.","journal-title":"Hepatol Res"},{"key":"1809_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jaut.2009.02.005","volume":"32","author":"P Chr\u00e9tien","year":"2009","unstructured":"Chr\u00e9tien P, Chousterman M, Abd Alsamad I, et al. Non-organ-specific autoantibodies in chronic hepatitis C patients: association with histological activity and fibrosis. J Autoimmun. 2009;32:201\u20135.","journal-title":"J Autoimmun"},{"key":"1809_CR12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/hep.510260229","volume":"26","author":"AJ Czaja","year":"1997","unstructured":"Czaja AJ, Carpenter HA. Histological findings in chronic hepatitis C with autoimmune features. Hepatology. 1997;26:459\u201366.","journal-title":"Hepatology"},{"key":"1809_CR13","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","volume":"63","author":"European Association for the Study of the Liver","year":"2015","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines: autoimmune hepatitis. J Hepatol. 2015;63:971\u20131004.","journal-title":"J Hepatol"},{"key":"1809_CR14","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/hep.1840150403","volume":"15","author":"N Bach","year":"1992","unstructured":"Bach N, Thung SN, Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative analysis. Hepatology. 1992;15:572\u20137.","journal-title":"Hepatology"},{"key":"1809_CR15","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/hep4.1388","volume":"3","author":"CC Simoes","year":"2019","unstructured":"Simoes CC, Saldarriaga OA, Utay NS, et al. Direct-acting antiviral treatment of patients with hepatitis C resolves serologic and histopathologic features of autoimmune hepatitis. Hepatol Commun. 2019;3:1113\u201323.","journal-title":"Hepatol Commun"},{"key":"1809_CR16","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1177\/2050640618791053","volume":"6","author":"M Enomoto","year":"2018","unstructured":"Enomoto M, Ikura Y, Tamori A, et al. Short-term histological evaluations after achieving a sustained virologic response to direct-acting antiviral treatment for chronic hepatitis C. United Eur Gastroenterol J. 2018;6:1391\u2013400.","journal-title":"United Eur Gastroenterol J"},{"key":"1809_CR17","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/hepr.12621","volume":"46","author":"E Miyaki","year":"2016","unstructured":"Miyaki E, Imamura M, Hiraga N, et al. Daclatasvir and asunaprevir treatment improves liver function parameters and reduces liver fibrosis markers in chronic hepatitis C patients. Hepatol Res. 2016;46:756\u201364.","journal-title":"Hepatol Res"},{"key":"1809_CR18","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/liv.13256","volume":"37","author":"JA Bachofner","year":"2017","unstructured":"Bachofner JA, Valli PV, Kr\u00f6ger A, et al. Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index. Liver Int. 2017;37:369\u201376.","journal-title":"Liver Int"},{"key":"1809_CR19","first-page":"642","volume":"66","author":"T Toyofuku","year":"2017","unstructured":"Toyofuku T, Hirano K, Ichida T. Clinical significance of M2BPGi measurement in HCV treatment. Jpn J Med Technol. 2017;66:642\u20138.","journal-title":"Jpn J Med Technol"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-023-01809-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-023-01809-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-023-01809-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T18:36:44Z","timestamp":1689791804000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-023-01809-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1809"],"URL":"https:\/\/doi.org\/10.1007\/s12328-023-01809-7","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,28]]},"assertion":[{"value":"21 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None of the authors have any conflicts of interest to declare with regards to this report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human\/animal rights"}},{"value":"Informed consent was obtained from the patient of this report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}